Navigation Links
New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
Date:11/1/2008

rial with the general applicability of a 'real-world' study, since it included all patients at our clinic who initiated hepatitis C treatment and met basic eligibility criteria," said Professor Colombo. "The results from this study prove that treatment success rates in the real world can be comparable to those achieved in clinical trials. The study also demonstrates that PEGASYS regimens enable significantly more patients to achieve a SVR."

PEGASYS has demonstrated efficacy in a broad range of patient types, even those with poor prognostic factors.(2)(3)(4)(5)(6)

About Hepatitis C

Hepatitis C is a blood-borne infectious disease of the liver and a leading cause of cirrhosis, liver cancer and the need for liver transplants. According to the Centers for Disease Control and Prevention (CDC), an estimated 4.1 million Americans (1.6 percent) have been infected with hepatitis C; 3.2 million are chronically infected. The number of new infections per year has declined from an average of 240,000 in the 1980s to about 26,000 in 2004. CDC estimates the number of hepatitis C-related deaths could increase to 38,000 annually by the year 2010, surpassing annual HIV/AIDS deaths.

About PEGASYS

PEGASYS, in combination with COPEGUS (ribavirin), is indicated for the treatment of adults with chronic hepatitis C who have compensated liver disease and have not previously been treated with interferon alpha. Efficacy has been demonstrated in patients with compensated liver disease and histological evidence of cirrhosis (Child-Pugh class A) and patients with HIV disease that are clinically stable (e.g., antiretroviral therapy not required or receiving stable antiretroviral therapy). In addition, PEGASYS in combination with COPEGUS is the first and only FDA-approved regimen for the treatment of chronic hepatitis C in patients coinfected with hepatitis C and HIV. PEGASYS is the only pegylated interferon indicated for the treatment of adult patients with chroni
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New International Study Shows Women With Symptomatic Fibroids Delaying Treatment Despite Substantial Burden on Quality of Life
2. Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD
3. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
4. Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds
5. NCI Funded Clinical Trial to Study Treatment of Breast Cancer Using Cryoablation
6. Nuvo Research presents positive Phase III study results for Pennsaid at leading rheumatology conference
7. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
9. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
10. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
11. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Levi & ... Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning possible violations ... issued by the Company in connection with its study ... TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact Joseph E. ... or by telephone at (212) 363-7500, toll-free: (877) ...
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies of ... field of holographic medical imaging, is entering the world ... campaign. Launching on April 20 th , 2015, the ... Pro. The 8-inch and 22-inch displays will allow consumers ... the first time. In addition to the two displays, ...
(Date:3/27/2015)... 2015 A new report from Kalorama Information says ... – Chile , Colombia ... for IVD firms.  The healthcare research firm said that while ... for the Latin American continent with a population of over ... operations. However, the country,s regional economic clout does not necessarily ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... BETHLEHEM, Pa., Oct. 26 A landmark study ... French hospitals over a two-year period has confirmed ... offer significantly better protection against accidental needlestick injuries ... as semi-automatic (push-button) devices or those with manually ...
... Md., Oct. 26 MedAvante, Inc., the leader ... (CNS) disorders, and Rexahn Pharmaceuticals, Inc. (NYSE Amex: ... company developing and commercializing potential best in class ... use MedAvante ,s Remote Centralized Ratings™ in their ...
Cached Medicine Technology:Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 2Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 3Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention 4Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study 2Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study 3
(Date:3/29/2015)... March 29, 2015 Adults who are ... promote nationally on the web can now use the ... insurance quotes can now be explored while researching the ... , Learning the differences between what a term policy ... a challenge for some men and women. Insurers typically ...
(Date:3/29/2015)... Chicago, IL (PRWEB) March 29, 2015 ... Foundation for Women’s Cancer announce today that ... 2015 recipient of the Claudia Cohen Research Foundation Prize ... presented at the Society of Gynecologic Oncology 46th Annual ... is Director of the Cedars-Sinai Women’s Cancer Program at ...
(Date:3/29/2015)... Washington, D.C. USA (PRWEB) March 29, 2015 ... Afro Health Link platform provides basic health ... them the opportunity to discuss these challenges as ... them. Afro Health Link addresses six medical conditions ... and encourage users to engage in conversations around ...
(Date:3/29/2015)... 29, 2015 North American Seminars receives ... Online Continuing Education Courses . , Utilizing ... CME - TPTA, approval # 56399TX      , ... the shoulder complex - 10.5 hours - Texas Board ... Examination and Treatment of the SI Joint - 10 ...
(Date:3/28/2015)... 2015 Coffee could not only perk you ... from gum disease, researchers have found. , They found that ... Coffee contains antioxidants. Antioxidants fight gum disease. Does coffee, then, ... Boston Univ. Henry M. Goldman School of Dental Medicine explored ... issue of the Journal of Periodontology. , “This is the ...
Breaking Medicine News(10 mins):Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2
... ... injury attorney, results in payment to an underage passenger hurt in a vehicle crash after ... ... Mark Gemma underscores the liability homeowners face when they allow underage drinking in ...
... ... latest information about clinics, camps, academies and events at Sea Colony - The Premier ... just north of Ocean City, Maryland. , ... Sea Colony, Bethany Beach, Del. (PRWEB) February 12, 2010 -- ...
... ANDREWS, Texas , Feb. 11 It took the jury ... for Anne Mitchell, RN , defendant in the criminal trial that ... trial. Mitchell faced a third-degree felony charge in Texas of ... Board for what she believed was unsafe patient care. Mitchell is a ...
... coronary artery , THURSDAY, Feb. 11 (HealthDay News) -- Former ... Thursday evening in a New York City hospital after he ... , The 63-year-old Clinton, who underwent quadruple bypass surgery in ... reports. , "Today President Bill Clinton was admitted to ...
... , , , ... 11 /PRNewswire-Asia-FirstCall/ -- China Cord Blood,Corporation ("CCBC" or ... leading provider of,cord blood collection, laboratory testing, hematopoietic ... that the Securities and,Exchange Commission ("SEC") declared the Company,s ...
... stress disorder (PTSD) threatens to overload healthcare and ... cases rises and existing treatments are not sufficiently ... technology, such as virtual reality, to alleviate the ... solutions are explored in a special issue of ...
Cached Medicine News:Health News:Rhode Island Settlement Reflects Homeowner Liability for Serving Alcohol to Those Under 21, Says Providence Lawyer Mark Gemma 2Health News:New SeaColonyTennis.net Launches to Promote World-Class Tennis Programs at Sea Colony 2Health News:Not Guilty - Texas Jury Acquits Winkler County Nurse 2Health News:Not Guilty - Texas Jury Acquits Winkler County Nurse 3Health News:Ex-President Clinton Undergoes Heart Procedure 2Health News:China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC 2Health News:Virtual reality and other technologies offer hope 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: